{"id":"https://openalex.org/W4389230218","doi":"https://doi.org/10.1182/blood-2023-177682","title":"Pembrolizumab with Rituximab in Relapsed/Refractory Follicular Lymphoma and Diffuse Large B Cell Lymphoma","display_name":"Pembrolizumab with Rituximab in Relapsed/Refractory Follicular Lymphoma and Diffuse Large B Cell Lymphoma","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389230218","doi":"https://doi.org/10.1182/blood-2023-177682"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-177682","doi":"https://doi.org/10.1182/blood-2023-177682","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-177682","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088009215","display_name":"Carrie Ho","orcid":"https://orcid.org/0000-0003-4437-9377","observed_orcids":["https://orcid.org/0000-0003-4437-9377"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie I Ho","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K Gopal","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079426839","display_name":"Chaitra Shankar Ujjani","orcid":"https://orcid.org/0000-0003-1977-1510","observed_orcids":["https://orcid.org/0000-0003-1977-1510","https://orcid.org/0000-0003-2662-4826"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaitra S Ujjani","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005281918","display_name":"Ryan C. Lynch","orcid":"https://orcid.org/0000-0001-6703-0894","observed_orcids":["https://orcid.org/0000-0001-6703-0894"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan C Lynch","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054146743","display_name":"Christina Poh","orcid":"https://orcid.org/0000-0003-3120-712X","observed_orcids":["https://orcid.org/0000-0003-3120-712X"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Poh","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057524392","display_name":"Jenna M. Voutsinas","orcid":"https://orcid.org/0000-0002-7474-4892","observed_orcids":["https://orcid.org/0000-0002-7474-4892"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenna M Voutsinas","raw_affiliation_strings":["2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027819567","display_name":"Qian Vicky Wu","orcid":"https://orcid.org/0000-0002-2292-4816","observed_orcids":["https://orcid.org/0000-0002-2292-4816"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qian Wu","raw_affiliation_strings":["2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069259642","display_name":"Jacquelin Vandermeer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacquelin Vandermeer","raw_affiliation_strings":["2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020858509","display_name":"Jonathan R. Fromm","orcid":"https://orcid.org/0000-0002-2287-5284","observed_orcids":["https://orcid.org/0000-0002-2287-5284"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan R Fromm","raw_affiliation_strings":["3Division of Hematopathology, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Hematopathology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088459737","display_name":"Stephen Douglas Smith","orcid":"https://orcid.org/0000-0001-5354-7593","observed_orcids":["https://orcid.org/0000-0001-5354-7593"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen D Smith","raw_affiliation_strings":["1Division of Hematology and Oncology, University of Washington, Seattle, WA","2Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology and Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"2Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"6144","last_page":"6144"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-follicular-lymphoma","display_name":"relapsed/refractory follicular lymphoma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/obinutuzumab","display_name":"obinutuzumab","score":0.9169999957084656},{"id":"https://openalex.org/keywords/anti-cd20-therapy","display_name":"anti-CD20 therapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/rituximab-refractory-disease","display_name":"rituximab-refractory disease","score":0.8370000123977661},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7940000295639038},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5680000185966492},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5569999814033508},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8770759105682373},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8111681938171387},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6926210522651672},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6651843786239624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6430331468582153},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5126892328262329},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.49194785952568054},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48030799627304077},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.477338582277298},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.47522929310798645},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45311108231544495},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.4170660376548767},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28568577766418457},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18569758534431458},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.15838298201560974},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-177682","doi":"https://doi.org/10.1182/blood-2023-177682","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-177682","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2914339623","https://openalex.org/W2791168547","https://openalex.org/W2621505397","https://openalex.org/W4387729316","https://openalex.org/W4205778306","https://openalex.org/W4200188834","https://openalex.org/W3135800925","https://openalex.org/W2121770645","https://openalex.org/W4403302463","https://openalex.org/W2549524390"],"abstract_inverted_index":{"Background:":[0],"The":[1],"tumor":[2,247],"microenvironment":[3],"(TME)":[4],"plays":[5],"a":[6,36,59,524,550,657],"role":[7],"in":[8,20,40,71,102,188,275,286,308,384,406,471,481,604,619,639,677,692],"follicular":[9],"lymphoma":[10,22,79,554],"(FL)":[11],"pathogenesis":[12],"and":[13,30,67,74,107,143,181,221,232,252,278,296,333,342,371,373,382,388,399,418,452,547,555,560,584,607,626,641,674,680,682],"survival.":[14],"PD-1/PDL-1":[15],"inhibitors":[16],"have":[17,138,144,153],"been":[18],"effective":[19],"non-Hodgkin":[21],"subtypes,":[23],"such":[24],"as":[25,194,455],"primary":[26],"mediastinal":[27],"B-cell":[28],"lymphoma,":[29,538],"pembrolizumab":[31],"+":[32,118],"rituximab":[33],"(P-R)":[34],"produced":[35],"complete":[37],"response":[38,97,262],"(CR)":[39],"50%":[41],"of":[42,69,100,184,236,270,281,321,377,416,462,473,528,552,581,592,663,671,685],"patients":[43,130,136,151,171,210,274,285,298,312,345,395,405,438,484,609],"with":[44,116,172,217,356,358,475,521,586,612,617,644],"rituximab-sensitive,":[45],"relapsed/refractory":[46],"(R/R)":[47],"FL":[48,73,104,123,606,620,679],"(Nastoupil":[49],"ASH":[50],"2017,":[51],"Blood":[52,624],"Adv":[53],"2022).":[54],"In":[55,207,301,391,424,434,446],"2018,":[56],"we":[57,650],"conducted":[58],"phase":[60,86],"2":[61,205,230,383,489,517],"study":[62,349,588],"to":[63,93,167,204,229,289,292,316,318,361,411,544,564,568,652,661,688],"assess":[64],"the":[65,95,271,282,309,587,690],"efficacy":[66,571,603,655],"safety":[68],"P-R":[70,101,596],"R/R":[72,103,108,122,132,605,678],"diffuse":[75],"large":[76],"B":[77,408,561],"cell":[78,162],"(DLBCL)":[80],"including":[81,516],"rituximab-resistant":[82,664],"patients.":[83,323,465,594,665],"Methods:":[84],"This":[85],"2,":[87],"single-center,":[88],"open-label,":[89],"non-randomized":[90],"trial":[91],"aimed":[92],"determine":[94],"objective":[96],"rate":[98],"(ORR)":[99],"(Arm":[105,110,127,294,299],"A)":[106,295],"DLBCL":[109,608,630],"B).":[111,300],"A":[112,165,258,559],"3":[113,240,269,280,449,593],"rd":[114],"arm":[115],"P":[117,185,200,226],"Obinutuzumab":[119],"(O)":[120],"for":[121,134,147,149,159,202,227,245,329,572],"was":[124,243,368,379,428,577],"added":[125],"later":[126],"C).":[128],"Eligible":[129],"had":[131,396,420],"disease;":[133],"FL,":[135],"must":[137,152],"received":[139,211],"prior":[140,375,545],"anti-CD20":[141,673],"therapy":[142,378,676],"an":[145],"indication":[146],"treatment;":[148],"DLBCL,":[150,681],"relapsed":[154],"after":[155,249,579],"or":[156,401],"be":[157,314],"ineligible":[158],"autologous":[160],"stem":[161],"transplantation.":[163],"Arm":[164,208,276,287,302,392,407,425,435,447,575],"sought":[166],"include":[168],">":[169,422],"9":[170,284,359,476],"rituximab-refractory":[173,397],"disease.":[174],"Weekly":[175],"R":[176],"375":[177],"mg/m2":[178],"x":[179,214],"4":[180,182,251,265],"doses":[183,235],"(200":[186],"mg":[187],"q21":[189],"day":[190],"cycles)":[191],"were":[192,327,346,353,409,450,509,532],"given":[193,238],"induction;":[195],"responders":[196],"could":[197,224],"receive":[198,225],"extended":[199],"monotherapy":[201],"up":[203,228,527],"years.":[206],"C,":[209,303,448],"weekly":[212],"O":[213,237],"4;":[215],"those":[216,654],"at":[218,263,267,304],"least":[219,268,305],"SD":[220,454],"clinical":[222],"benefit":[223],"years":[231],"6":[233,306,535],"more":[234],"every":[239,255],"months.":[241],"CT":[242],"used":[244],"on-treatment":[246],"assessments":[248],"cycles":[250],"8,":[253],"then":[254],"12":[256,311],"weeks.":[257],"2-stage":[259],"design":[260],"required":[261],"cycle":[264],"among":[266,279],"first":[272,283,310],"7":[273],"A,":[277,386,393,426],"B,":[288,387,436],"permit":[290],"accrual":[291,320,591],"20":[293],"17":[297],"responses":[307,583],"would":[313],"needed":[315],"proceed":[317],"total":[319],"25":[322],"Additional":[324],"stopping":[325],"rules":[326],"included":[328],"excess":[330],"deaths":[331],"(>10%)":[332],"serious":[334],"adverse":[335,467],"events":[336,468],"(SAEs)":[337],"(>50%).":[338],"Results:":[339],"Between":[340],"4/2018":[341],"11/2021,":[343],"18":[344],"treated":[347,355,520,611],"on":[348],"(Table":[350],"1).":[351],"All":[352,404],"previously":[354,610],"rituximab,":[357],"refractory":[360,410],"their":[362,412],"last":[363],"rituximab-containing":[364],"regimen.":[365],"Median":[366],"age":[367,640],"56,":[369],"78,":[370],"45":[372],"median":[374,525],"lines":[376],"4,":[380],"3,":[381],"Arms":[385,558],"C":[389,576],"respectively.":[390],"2/7":[394],"disease,":[398],"int-":[400],"high-risk":[402],"FLIPI.":[403],"most":[413],"recent":[414],"line":[415],"therapy,":[417,546],"75%":[419],"IPI":[421],"3.":[423],"ORR":[427,632],"29%":[429],"(1":[430,485],"CR,":[431],"1":[432,442,444,459,491,493,495,498,501,505,539,548],"PR).":[433],"no":[437,582],"responded":[439],"(6":[440],"PD,":[441],"SD,":[443],"unevaluable).":[445],"accrued":[451,464],"achieved":[453],"best":[456],"response.":[457],"Figure":[458],"shows":[460],"outcomes":[461],"all":[463],"Treatment-related":[466],"(AE)":[469],"occurred":[470],"83%":[472],"patients,":[474],"grade":[477,512],"3/4":[478,513],"AEs":[479],"occurring":[480],"5":[482,510],"(28%)":[483],"acute":[486],"kidney":[487],"injury,":[488],"diarrhea,":[490],"hypokalemia,":[492],"arthralgia,":[494],"infusion":[496],"reaction,":[497],"back":[499],"pain,":[500],"generalized":[502],"muscle":[503],"weakness,":[504],"heart":[506],"failure).":[507],"There":[508],"possible":[511],"immune-related":[514],"AEs,":[515],"suspected":[518],"colitis":[519],"steroids.":[522],"With":[523],"follow":[526],"4.2":[529],"years,":[530],"there":[531],"8":[533],"deaths,":[534],"from":[536,540,549,628,646],"progressive":[537,553],"AML":[541],"likely":[542],"related":[543],"combination":[551],"therapy-related":[556],"AML.":[557],"closed":[562,578],"due":[563],"futility,":[565],"having":[566],"failed":[567,651],"exceed":[569],"minimum":[570],"further":[573],"accrual.":[574],"demonstration":[580],"discussion":[585],"sponsor":[589],"following":[590],"Conclusion:":[595],"has":[597],"modest,":[598],"expected":[599],"toxicity":[600],"but":[601],"low":[602],"R.":[613],"Our":[614,666],"data":[615,627,645,667],"align":[616],"CHECKMATE-140":[618],"(4%":[621],"ORR,":[622],"Armand":[623],"2021)":[625],"post-transplant":[629],"(10%":[631],"post-ASCT,":[633],"Ansell":[634],"JCO":[635],"2019).":[636],"Despite":[637],"similarities":[638],"FLIPI":[642],"distribution":[643],"Nastoupil":[647],"et":[648],"al,":[649],"confirm":[653],"findings,":[656],"finding":[658],"partly":[659],"attributable":[660],"inclusion":[662],"suggest":[668],"limited":[669],"utility":[670],"combined":[672],"anti-PD-1":[675],"support":[683],"exploration":[684],"alternative":[686],"strategies":[687],"target":[689],"TME":[691],"these":[693],"diseases.":[694]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-02T00:00:00"}